Abstract:Summary.-Immunofluorescent assessment of hormone receptors in melanocytic tumours is quite feasible without loss of diagnostic material, in contrast to the impracticability of quantitative biochemical assays. Using this method, oestrogen receptors were demonstrated in 4/6, and progesterone receptors in 3/5 patients with metastatic melanoma. Receptors were not found in 3 patients with primary cutaneous melanomas of the superficial spreading type. Progesterone receptors were present in the junctional component o… Show more
“…Estrogen receptors have been found on melanoma cells (Grill et al, 1982; Ellis et al, 1985a,b; Ellis and Wheeland, 1986; Thompson et al, 1981). The fact that female hormones may have a protective effect in patients with MM (Briele et al, 1983) possibly is a factor in why females have thinner lesions.…”
Section: Section VIImentioning
confidence: 99%
“… Brocker et al, 1984, 1985; Bumol and Reisfeld, 1982; Ellis et al, 1985b; Ellis and Wheeland, 1986; Halpern et al, 1985; Hearing, 1981; Herlyn et al, 1983; Hersey, 1985; Imai et al, 1981; Imam et al, 1986; Kantor et al, 1982; Knudsen et al, 1982; Kozlowski et al, 1984; Natali et al, 1983a,b, 1985; Nicolson, 1982; Real et al, 1985; Ruiter et al, 1985; Sherwin et al, 1979; Stefansson et al, 1982; Thompson et al, 1981; Tomita et al, 1985; Wakabayashi et al, 1984; Watanabe et al, 1982. …”
“…Estrogen receptors have been found on melanoma cells (Grill et al, 1982; Ellis et al, 1985a,b; Ellis and Wheeland, 1986; Thompson et al, 1981). The fact that female hormones may have a protective effect in patients with MM (Briele et al, 1983) possibly is a factor in why females have thinner lesions.…”
Section: Section VIImentioning
confidence: 99%
“… Brocker et al, 1984, 1985; Bumol and Reisfeld, 1982; Ellis et al, 1985b; Ellis and Wheeland, 1986; Halpern et al, 1985; Hearing, 1981; Herlyn et al, 1983; Hersey, 1985; Imai et al, 1981; Imam et al, 1986; Kantor et al, 1982; Knudsen et al, 1982; Kozlowski et al, 1984; Natali et al, 1983a,b, 1985; Nicolson, 1982; Real et al, 1985; Ruiter et al, 1985; Sherwin et al, 1979; Stefansson et al, 1982; Thompson et al, 1981; Tomita et al, 1985; Wakabayashi et al, 1984; Watanabe et al, 1982. …”
“…We are currently investigating this possibility. Previous studies have shown an occasional positive “normal nevus, “ 4, 9, 14 but controls have not been well defined. One study by Chadhuri and colleagues 15 found that 41% of benign nevi from patients with melanoma were positive for estrogen receptors, stressing that control patient populations must be rigidly outlined.…”
Section: Commentsmentioning
confidence: 97%
“…This method allows visualization of the cells that bind the fluorescent hormones. One previous report used a similar assay, with negative fluorescence obtained on three primary superficial spreading melanomas 9 . We also did estrogen‐ and progesterone‐binding studies on nevi from a control male and female patient population.…”
mentioning
confidence: 99%
“…Since the original report by Fisher and colleagues 1 several studies have described hormonal receptors in human malignant melanoma. Melanomas were previously found to have from 0 to 78% positive estrogen receptors and from 0 to 100% positive progesterone receptors 2–9 . Much of these data are difficult to evaluate since either small numbers of primary lesions were studied or the lesions were not classified as primary or metastatic.…”
Using a variety of techniques, estrogen and progesterone receptors have previously been identified in variable percentages of malignant melanomas. We examined 10 primary superficial spreading melanomas (SSM) with a fluorescent hormone-binding technique for estrogen and progesterone cytoplasmic receptors. Of these 6 SSM were markedly positive for estrogen and progesterone binding. Patients with dysplastic nevus syndrome (DNS) or a family history of DNS were markedly positive for estrogen and progesterone binding. A single patient with lentigo maligna and another patient with lentigo maligna melanoma were negative for estrogen and progesterone binding. None of the 21 control intradermal nevi examined for estrogen and progesterone binding exhibited marked positivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.